Views: 0 Author: Site Editor Publish Time: 2026-05-04 Origin: Site
Ursodeoxycholic Acid CAS 128-13-2, commonly known as UDCA, is an important bile acid widely used in the pharmaceutical industry for the treatment of liver and gallbladder diseases. As a naturally occurring hydrophilic bile acid, Ursodeoxycholic acid API has gained global recognition for its ability to improve bile flow, protect liver cells, and dissolve cholesterol gallstones.
Today, with increasing demand for high-quality hepatoprotective drugs, many active pharmaceutical ingredient suppliers and active pharmaceutical ingredients from China manufacturers are focusing on the large-scale production of Ursodeoxycholic acid powder under GMP standards to meet international pharmaceutical requirements.
UDCA (Ursodeoxycholic Acid) is a secondary bile acid naturally found in small amounts in human bile. In pharmaceutical applications, it is produced through advanced chemical synthesis and purification technologies to achieve high purity suitable for medicinal use.
Unlike toxic hydrophobic bile acids, UDCA is hydrophilic and cytoprotective. It helps stabilize liver cell membranes, reduce bile toxicity, and improve bile secretion. Because of these properties, UDCA has become one of the most important therapeutic agents for chronic liver and biliary disorders.
One of the best-known clinical applications of Ursodeoxycholic acid API is the non-surgical treatment of cholesterol gallstones. UDCA works by:
Reducing cholesterol saturation in bile
Improving bile flow
Gradually dissolving cholesterol stones
This makes it an important alternative for patients who are unsuitable for surgery.
UDCA is widely used in the management of:
Primary biliary cholangitis (PBC)
Intrahepatic cholestasis
Chronic cholestatic liver disorders
By improving bile acid composition and reducing bile accumulation, UDCA helps protect hepatocytes from long-term inflammatory damage.
Research has shown that UDCA possesses significant hepatoprotective properties. It can:
Reduce oxidative stress in liver cells
Suppress inflammatory responses
Improve liver enzyme levels
Prevent apoptosis of hepatocytes
Because of these effects, UDCA is frequently used as supportive therapy in various liver dysfunction conditions.
Recent studies are exploring the potential of Ursodeoxycholic acid powder in:
Non-alcoholic fatty liver disease (NAFLD)
Drug-induced liver injury
Gastrointestinal and metabolic disorders
These emerging applications continue to expand the pharmaceutical importance of UDCA worldwide.
The production of Ursodeoxycholic acid API requires strict control over synthesis, purification, and crystallization processes to ensure pharmaceutical-grade purity and stability. Leading Ursodeoxycholic acid bulk manufacturer GMP facilities focus on:
High purity production standards
Controlled impurity profiles
Stable crystal forms
Compliance with international GMP regulations
Modern manufacturing technologies also improve overall yield and environmental sustainability, making UDCA production more efficient and globally competitive.
In recent years, active pharmaceutical ingredients from China have become increasingly important in the global healthcare supply chain. Chinese manufacturers now supply high-quality Ursodeoxycholic acid powder to pharmaceutical companies worldwide, supported by:
Advanced manufacturing capabilities
Cost-effective large-scale production
International regulatory compliance
Stable export capacity
As a result, China has become a key hub for reliable active pharmaceutical ingredient suppliers serving both regulated and emerging pharmaceutical markets.
Ursodeoxycholic Acid CAS 128-13-2 (UDCA) is a clinically important bile acid with proven benefits in liver protection, bile regulation, and gallstone dissolution. From traditional hepatobiliary therapy to emerging metabolic applications, Ursodeoxycholic acid API continues to play a critical role in modern medicine.
Supported by advanced production technologies and trusted Ursodeoxycholic acid bulk manufacturer GMP facilities, UDCA remains one of the most valuable pharmaceutical raw materials in the global healthcare industry.
